ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Amyris makes cannabigerol via fermentation

by Melody M. Bomgardner
September 4, 2020 | APPEARED IN VOLUME 98, ISSUE 34

 

09834-buscon10-canna.jpg

Amyris, a producer of fermentation-derived ingredients, says it has scaled up production of cannabigerol (CBG), a cannabinoid that can be used in skin-care and cosmetic products. CBG is the precursor of two more famous cannabinoids: cannabidiol (CBD) and tetrahydrocannabinol (THC). Like CBD, CBG does not produce a high but may have therapeutic benefits. Amyris says its yeast-fermentation route is less costly than extracting the compound from plants. The firm expects to begin sales this year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment